{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:41:07Z","timestamp":1792644067228,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":1898,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL126724"],"award-info":[{"award-number":["HL126724"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL115187"],"award-info":[{"award-number":["HL115187"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK007545"],"award-info":[{"award-number":["DK007545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1111\/jth.13764","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T15:06:44Z","timestamp":1498748804000},"page":"1889-1900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics"],"prefix":"10.1016","volume":"15","author":[{"given":"M.","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.K.","family":"McDaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.L.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13764_bb0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13764_bb0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.pathmechdis.3.121806.154311","article-title":"Pathogenesis of thrombotic microangiopathies","volume":"3","author":"Zheng","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"10.1111\/jth.13764_bb0020","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","article-title":"The incidence of thrombotic thrombocytopenic purpura\u2010hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS\u201013 deficiency","volume":"3","author":"Terrell","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0025","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic\u2010uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13764_bb0030","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/jth.13764_bb0035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0040","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic\u2010uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13764_bb0045","first-page":"21","article-title":"Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease","volume":"24","author":"Moschcowitz","year":"1924","journal-title":"Proc NY Pathol Soc"},{"key":"10.1111\/jth.13764_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura: report of 16 cases and reveiw of the literature","volume":"45","author":"Amorosi","year":"1966","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/jth.13764_bb0055","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-11-4035","article-title":"Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0060","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura\u2010hemolytic uremic syndrome. Clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13764_bb0065","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13764_bb0070","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","article-title":"Deficient activity of von Willebrand factor\u2010cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura","volume":"89","author":"Furlan","year":"1997","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0075","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor\u2010cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1111\/jth.13764_bb0080","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor\u2010cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13764_bb0085","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V98.6.1654","article-title":"Partial amino acid sequence of purified von Willebrand factor\u2010cleaving protease","volume":"98","author":"Gerritsen","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0090","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","article-title":"Purification of human von Willebrand factor\u2010cleaving protease and its identification as a new member of the metalloproteinase family","volume":"98","author":"Fujikawa","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1111\/jth.13764_bb0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jth.12221","article-title":"Structure\u2010function and regulation of ADAMTS\u201013 protease","volume":"11","author":"Zheng","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1111\/jth.13764_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS\u2010VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13764_bb0115","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1055\/s-0037-1614780","article-title":"Assay of von Willebrand factor (vWF)\u2010cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)","volume":"82","author":"Gerritsen","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0120","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2013-02-486779","article-title":"AAV\u2010mediated expression of an ADAMTS13 variant prevents shigatoxin\u2010induced thrombotic thrombocytopenic purpura","volume":"121","author":"Jin","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0125","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2014-07-587139","article-title":"Platelet\u2010delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models","volume":"125","author":"Pickens","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0130","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1182\/blood-2011-12-399501","article-title":"Gain\u2010of\u2010function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura","volume":"119","author":"Jian","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0135","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/ATVBAHA.115.306014","article-title":"Potential for recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura","volume":"35","author":"Tersteeg","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13764_bb0140","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13764_bb0145","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.4172\/2161-1041.1000e104","article-title":"ADAMTS13, TTP and beyond","volume":"2","author":"Zheng","year":"2013","journal-title":"Hereditary Genet"},{"key":"10.1111\/jth.13764_bb0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13764_bb0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2141.2005.05837.x","article-title":"Prognostic value of inhibitory anti\u2010ADAMTS13 antibodies in adult\u2010acquired thrombotic thrombocytopenic purpura","volume":"132","author":"Coppo","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13764_bb0165","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor\u2010cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic\u2010uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13764_bb0170","doi-asserted-by":"crossref","first-page":"e64097","DOI":"10.1371\/journal.pone.0064097","article-title":"Gastrointestinal and extra\u2010intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic","volume":"8","author":"Khan","year":"2013","journal-title":"PLoS One"},{"key":"10.1111\/jth.13764_bb0175","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1994.03520170059036","article-title":"A multistate outbreak of Escherichia coli O157: H7\u2010associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience","volume":"272","author":"Bell","year":"1994","journal-title":"JAMA"},{"key":"10.1111\/jth.13764_bb0180","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux\u2010Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/jth.13764_bb0185","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic\u2010uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"10.1111\/jth.13764_bb0190","article-title":"Increased troponin I is associated with fatal outcome in acquired thrombotic thrombocytopenic purpura","author":"Brazelton","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1111\/jth.13764_bb0195","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jth.12826","article-title":"Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity","volume":"13","author":"Zafrani","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0200","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13764_bb0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1751-553X.2011.01380.x","article-title":"ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes","volume":"34","author":"Zini","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.13764_bb0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant\u2010associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1111\/jth.13764_bb0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jca.20017","article-title":"Frequency and significance of schistocytes in TTP\/HUS patients at the discontinuation of plasma exchange therapy","volume":"19","author":"Egan","year":"2004","journal-title":"J Clin Apher"},{"key":"10.1111\/jth.13764_bb0220","first-page":"1","article-title":"Atypical hemolytic uremic syndrome (aHUS): making the diagnosis","volume":"10","author":"Laurence","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1111\/jth.13764_bb0225","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5858\/arpa.2013-0170-OA","article-title":"Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura","volume":"138","author":"Barrows","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/jth.13764_bb0230","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1160\/TH12-08-0565","article-title":"Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies","volume":"109","author":"Mackie","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0235","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody\u2010based enzyme immunoassay for determining plasma levels of ADAMTS13 activity","volume":"46","author":"Kato","year":"2006","journal-title":"Transfusion"},{"key":"10.1111\/jth.13764_bb0240","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1538-7836.2006.01758.x","article-title":"A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption\/ionization time\u2010of\u2010flight (SELDI\u2010TOF)\u2010mass spectrometry","volume":"4","author":"Jin","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0245","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ajh.20097","article-title":"Simplified assay for VWF cleaving protease (ADAMTS13) activity and inhibitor in plasma","volume":"76","author":"Knovich","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13764_bb0250","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1538-7836.2007.02438.x","article-title":"Hyperbilirubinemia interferes with ADAMTS\u201013 activity measurement by FRETS\u2010VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies","volume":"5","author":"Meyer","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0255","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/jth.12319","article-title":"An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura","volume":"11","author":"Muia","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0260","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS One"},{"key":"10.1111\/jth.13764_bb0265","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1111\/jth.13764_bb0270","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/bjh.12303","article-title":"Ticlopidine\u2010associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR)","volume":"161","author":"Bennett","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13764_bb0275","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-0032-1328894","article-title":"Ticlopidine\u2010, clopidogrel\u2010, and prasugrel\u2010associated thrombotic thrombocytopenic purpura: a 20\u2010year review from the Southern Network on Adverse Reactions (SONAR)","volume":"38","author":"Jacob","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13764_bb0280","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jca.20194","article-title":"Is it quinine TTP\/HUS or quinine TMA? ADAMTS13 levels and implications for therapy","volume":"24","author":"Park","year":"2009","journal-title":"J Clin Apher"},{"key":"10.1111\/jth.13764_bb0285","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood.V77.2.306.306","article-title":"Quinine\u2010induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity","volume":"77","author":"Gottschall","year":"1991","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0290","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.transproceed.2010.02.029","article-title":"Posttransplantation calcineurin inhibitor\u2010induced hemolytic uremic syndrome: single\u2010center experience","volume":"42","author":"Said","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1111\/jth.13764_bb0295","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0041-1345(00)00940-4","article-title":"Thrombotic microangiopathy early after kidney transplantation: hemolytic uremic syndrome or vascular rejection?","volume":"32","author":"Mor","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1111\/jth.13764_bb0300","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1600-6143.2003.00222.x","article-title":"Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation","volume":"3","author":"Karthikeyan","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/jth.13764_bb0305","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0272-6386(12)81010-9","article-title":"Transplant\u2010associated thrombotic microangiopathy: the role of IgG administration as initial therapy","volume":"23","author":"Hochstetler","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/jth.13764_bb0310","first-page":"54","article-title":"De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine","volume":"98","author":"Van Buren","year":"1985","journal-title":"Surgery"},{"key":"10.1111\/jth.13764_bb0315","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug\u2010associated thrombotic thrombocytopenic purpura\u2010hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/jth.13764_bb0320","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0272-6386(97)90042-1","article-title":"Endotheliopathy: a continuum of hemolytic uremic syndrome due to mitomycin therapy","volume":"29","author":"Groff","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/jth.13764_bb0325","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MD.0000000000000207","article-title":"Kidney diseases associated with anti\u2010vascular endothelial growth factor (VEGF): an 8\u2010year observational study at a single center","volume":"93","author":"Izzedine","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/jth.13764_bb0330","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/ndt\/gfl507","article-title":"Gemcitabine\u2010induced thrombotic microangiopathy: a systematic review","volume":"21","author":"Izzedine","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jth.13764_bb0335","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1097\/01.tp.0000226066.82066.fa","article-title":"Thrombotic microangiopathy with acquired deficiency in ADAMTS 13 activity in lung transplant recipients","volume":"81","author":"Mal","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/jth.13764_bb0340","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/j.1600-6143.2011.03612.x","article-title":"Complement activation during liver transplantation\u2010special emphasis on patients with atypical hemolytic uremic syndrome","volume":"11","author":"Koskinen","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/jth.13764_bb0345","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.lpm.2011.10.026","article-title":"Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer","volume":"41","author":"George","year":"2012","journal-title":"Presse Med"},{"key":"10.1111\/jth.13764_bb0350","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/jth.13764_bb0355","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MD.0b013e3182603598","article-title":"Cancer\u2010related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases","volume":"91","author":"Lechner","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/jth.13764_bb0360","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2141.2001.02704.x","article-title":"Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor\u2010cleaving protease","volume":"113","author":"Fontana","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13764_bb0365","first-page":"908","article-title":"Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia","volume":"25","author":"George","year":"2011","journal-title":"Oncology (Williston Park)"},{"key":"10.1111\/jth.13764_bb0370","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.amjhyper.2007.02.018","article-title":"The renin\u2010angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension","volume":"20","author":"van den Born","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1111\/jth.13764_bb0375","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(69)92221-1","article-title":"Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension","volume":"1","author":"Linton","year":"1969","journal-title":"Lancet"},{"key":"10.1111\/jth.13764_bb0380","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2040620715571076","article-title":"Differentiating malignant hypertension\u2010induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura","volume":"6","author":"Khanal","year":"2015","journal-title":"Ther Adv Hematol"},{"key":"10.1111\/jth.13764_bb0385","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/HYPERTENSIONAHA.107.103127","article-title":"Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension","volume":"51","author":"van den Born","year":"2008","journal-title":"Hypertension"},{"key":"10.1111\/jth.13764_bb0390","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw\u2010Schulman syndrome in pregnancy\u2010onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti\u2010Cohen","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0395","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.transci.2016.04.009","article-title":"Pregnancy\u2010related thrombotic microangiopathies: clues from complement biology","volume":"54","author":"Fakhouri","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"10.1111\/jth.13764_bb0400","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology","volume":"145","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13764_bb0405","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1160\/TH14-09-0731","article-title":"VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP","volume":"113","author":"Schwameis","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0410","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2005-03-1087","article-title":"Severe secondary deficiency of von Willebrand factor\u2010cleaving protease (ADAMTS13) in patients with sepsis\u2010induced disseminated intravascular coagulation: its correlation with development of renal failure","volume":"107","author":"Ono","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0415","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood-2012-02-412197","article-title":"Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies","volume":"120","author":"Fuchs","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0420","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/jth.12796","article-title":"Impaired DNase1\u2010mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies","volume":"13","author":"Jimenez\u2010Alcazar","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0425","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-3083.2008.02143.x","article-title":"Human immunodeficiency virus\u2010associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity","volume":"68","author":"Malak","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1111\/jth.13764_bb0430","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/sj.bmt.1703879","article-title":"Endothelial damage caused by cytomegalovirus and human herpesvirus\u20106","volume":"31","author":"Takatsuka","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/jth.13764_bb0435","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0037-1614408","article-title":"Recovery and half\u2010life of von Willebrand factor\u2010cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura","volume":"81","author":"Furlan","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13764_bb0440","series-title":"ADAMTS13 Biology and Disease","first-page":"73","article-title":"Hereditary deficiency of ADAMTS13 activity: Upshaw\u2010Schulman syndrome","author":"Fujimura","year":"2015"},{"key":"10.1111\/jth.13764_bb0445","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1182\/blood-2011-09-380535","article-title":"A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13","volume":"119","author":"Schiviz","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0450","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM197712222972507","article-title":"Treatment of thrombotic thrombocytopenic purpura with plasma","volume":"297","author":"Byrnes","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13764_bb0455","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0460","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-138-2-200301210-00011","article-title":"Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab","volume":"138","author":"Zheng","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.13764_bb0465","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1537-2995.2008.02082.x","article-title":"Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura","volume":"49","author":"Swisher","year":"2009","journal-title":"Transfusion"},{"key":"10.1111\/jth.13764_bb0470","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1182\/blood-2008-08-173021","article-title":"Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell\u2010mediated gene therapy","volume":"113","author":"Laje","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0475","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/ATVBAHA.116.308680","article-title":"Long\u2010term prevention of congenital thrombotic thrombocytopenic purpura in ADAMTS13 knockout mice by sleeping beauty transposon\u2010mediated gene therapy","volume":"37","author":"Verhenne","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13764_bb0480","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood-2016-09-738856","article-title":"N\u2010acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura","volume":"129","author":"Tersteeg","year":"2017","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0485","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/bloodadvances.2016000711","article-title":"Therapeutic efficacy of anfibatide in a murine model of thrombotic thrombocytopenic purpura (TTP)","volume":"1","author":"Zheng","year":"2016","journal-title":"Blood Adv"},{"key":"10.1111\/jth.13764_bb0490","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2012-04-420943","article-title":"Evaluation of efficacy and safety of the anti\u2010VWF Nanobody ALX\u20100681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura","volume":"120","author":"Callewaert","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0495","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V126.23.1147.1147","article-title":"Increased plasma levels of human neutrophil peptides (HNPs) and complement activation markers in patients with acquired thrombotic thrombocytopenic purpura (TTP)","volume":"126","author":"Cao","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13764_bb0500","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.1301221","article-title":"Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy","volume":"191","author":"Tati","year":"2013","journal-title":"J Immunol"},{"key":"10.1111\/jth.13764_bb0505","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3324\/haematol.2016.149021","article-title":"Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura","volume":"101","author":"Cao","year":"2016","journal-title":"Haematologica"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13764","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622043513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622043513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13764\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:16:51Z","timestamp":1761535011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622043513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1538783622043513"],"URL":"https:\/\/doi.org\/10.1111\/jth.13764","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}